UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

Clinical chemistry (Baltimore, Md.), 2014-01, Vol.60 (1), p.158-164

2014

Volltextzugriff (PDF)

Transcatheter aortic valve replacement: History and current status

Trends in cardiovascular medicine, 2013-07, Vol.23 (5), p.172-178

2013

Volltextzugriff (PDF)

Abstract 19221: Rates of Arterial Revascularization in Patients Treated with Vorapaxar vs. Placebo in the TRA 2°P-TIMI 50 Trial

Circulation (New York, N.Y.), 2012-11, Vol.126 (suppl_21)

2012

Volltextzugriff (PDF)

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2017-10, Vol.390 (10105), p.1833-1842

2017

Volltextzugriff (PDF)

European Society of Cardiology, ESC Congress 2015: Advisors’ Introduction

MD conference express, 2015-10, Vol.15 (28), p.ii-ii

2015

Volltextzugriff (PDF)

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.911-921

2017

Volltextzugriff (PDF)

Inflammatory and Cholesterol Risk in the FOURIER Trial

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.131-140

2018

Volltextzugriff (PDF)

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician

Circulation (New York, N.Y.), 2019-12, Vol.140 (24), p.2019-2037

2019

Volltextzugriff (PDF)

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

JACC. Basic to translational science, 2020-05, Vol.5 (5), p.518-536

2020

Volltextzugriff (PDF)

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2016-07, Vol.134 (1), p.24-36

2016

Volltextzugriff (PDF)

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117

2018

Volltextzugriff (PDF)

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361

2016

Volltextzugriff (PDF)

A current review of COVID-19 for the cardiovascular specialist

The American heart journal, 2020-08, Vol.226, p.29-44

2020

Volltextzugriff (PDF)

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke (1970), 2020-05, Vol.51 (5), p.1546-1554

2020

Volltextzugriff (PDF)

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Circulation (New York, N.Y.), 2015-09, Vol.132 (13), p.1224-1233

2015

Volltextzugriff (PDF)

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Circulation (New York, N.Y.), 2018-04, Vol.137 (15), p.1571-1582

2018

Volltextzugriff (PDF)

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2440-2450

2017

Volltextzugriff (PDF)

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel

Journal of the American College of Cardiology, 2020-09, Vol.76 (11), p.1345-1357

2020

Volltextzugriff (PDF)

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Circulation (New York, N.Y.), 2016-07, Vol.134 (4), p.304-313

2016

Volltextzugriff (PDF)

The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript

The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15991-15997

2003

Volltextzugriff (PDF)

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

European heart journal, 2023-01, Vol.44 (4), p.293-300

2023

Volltextzugriff (PDF)

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

The American heart journal, 2023-04, Vol.258, p.149-156

2023

Volltextzugriff (PDF)

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

European heart journal, 2016-12, Vol.37 (48), p.3576-3584

2016

Volltextzugriff (PDF)

COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-07, Vol.76 (1), p.72-84

2020

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

Transcatheter aortic valve replacement: History and current status

Abstract 19221: Rates of Arterial Revascularization in Patients Treated with Vorapaxar vs. Placebo in the TRA 2°P-TIMI 50 Trial

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

European Society of Cardiology, ESC Congress 2015: Advisors’ Introduction

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Inflammatory and Cholesterol Risk in the FOURIER Trial

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

A current review of COVID-19 for the cardiovascular specialist

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week

Suchergebnisse filtern